AstraZeneca India receives permission from DCGI for Dapagliflozin
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca
There is a pressing need for continuous improvement and innovation in food safety systems to keep pace with emerging food trends and habits
Health-tech startups have the potential to revolutionize the healthcare sector by supporting innovations
The CHMP’s recommendation will now be reviewed by the European Commission for marketing authorization in the European Union
The maker of ivermectin/pyrantel, the #1 vet-recommended and #1 dog-preferred real beef chew introduces the latest innovation in its portfolio
The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
First of its kind screening for Glaucoma at grass root level over 10k screened already
Evonik specializes in mid- to large-scale, later clinical phase HPAPIs
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
Subscribe To Our Newsletter & Stay Updated